GDNF and Parkinson disease: In subsequent studies, IN-GDNF was administered in chitosan-coated nano structured lipid carriers modified with cell-penetrating TAT peptides (NLC-TAT-GDNF), as well as unmodified GDNF and placebo to MPTP mouse models of PD.